Legend Biotech (LEGN) Showcases Updated and New Data from Comprehensive BCMA CAR-T, Cilta-Cel, Program and First Preclinical Results for Tri-specific CAR-T at 2021 ASH

Go back to Legend Biotech (LEGN) Showcases Updated and New Data from Comprehensive BCMA CAR-T, Cilta-Cel, Program and First Preclinical Results for Tri-specific CAR-T at 2021 ASH
(NASDAQ: LEGN) Delayed: 39.02 -0.14 (0.36%)
Previous Close $39.16    52 Week High
Open $39.54    52 Week Low
Day High $39.96    P/E N/A 
Day Low $38.53    EPS
Volume 141,868